KROS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.90%

Insider Buying (Last 12 Months): $9,464,033.54

Insider Selling (Last 12 Months): $11,002,500.00

Keros Therapeutics Insider Trading History Chart

Keros Therapeutics Share Price & Price History

^$14.07

▲ +0.54 (3.99%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

Keros Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/9/2025	Adar1 Capital Management, Llc	Major Shareholder	Buy	934,258	$10.13	$9,464,033.54	4,392,737
8/13/2024	Carl L Gordon	Director	Sell	250,000	$44.01	$11,002,500.00	119,522
6/8/2023	Keith Regnante	CFO	Sell	20,000	$47.79	$955,800.00
7/15/2022	Jennifer Lachey	Insider	Sell	46,034	$30.00	$1,381,020.00	95,100
7/13/2022	Jennifer Lachey	Insider	Sell	1,916	$30.00	$57,480.00	95,100
5/11/2022	Jennifer Lachey	Insider	Sell	5,300	$41.90	$222,070.00	85,700

SEC Filings (Institutional Ownership Changes) for Keros Therapeutics (NASDAQ:KROS)

71.56% of Keros Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Keros Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2025	FNY Investment Advisers LLC	2,500	$25K	0.0%	N/A	0.006%
4/8/2025	Rhumbline Advisers	44,669	$0.46M	0.0%	+9.3%	0.110%
4/7/2025	GAMMA Investing LLC	2,415	$0.24M	0.0%	+7,690.3%	0.006%
3/24/2025	Wellington Management Group LLP	14,033	$0.22M	0.0%	-6.1%	0.035%
2/21/2025	TFG Asset Management GP Ltd	103,000	$1.63M	0.3%	N/A	0.254%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	64,416	$1.02M	0.0%	+27.4%	0.159%
2/17/2025	Woodline Partners LP	387,701	$6.14M	0.0%	-49.2%	0.957%
2/17/2025	Twinbeech Capital LP	129,553	$2.05M	0.0%	+742.5%	0.320%
2/17/2025	Two Sigma Advisers LP	20,700	$0.33M	0.0%	+200.0%	0.051%
2/17/2025	Two Sigma Investments LP	33,664	$0.53M	0.0%	+226.1%	0.083%
2/17/2025	Tema Etfs LLC	35,663	$0.57M	0.2%	N/A	0.088%
2/17/2025	TFG Asset Management GP Ltd	103,000	$1.63M	0.4%	N/A	0.254%
2/17/2025	Rafferty Asset Management LLC	45,801	$0.73M	0.0%	+11.4%	0.113%
2/17/2025	Point72 Asset Management L.P.	1,592	$25K	0.0%	-99.8%	0.004%
2/17/2025	ProShare Advisors LLC	10,549	$0.17M	0.0%	+35.5%	0.026%
2/17/2025	Parkman Healthcare Partners LLC	314,541	$4.98M	0.7%	-25.4%	0.776%
2/17/2025	Nuveen Asset Management LLC	79,485	$1.26M	0.0%	-69.6%	0.196%
2/17/2025	Occudo Quantitative Strategies LP	103,408	$1.64M	0.3%	N/A	0.255%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	50,897	$0.81M	0.1%	+105.6%	0.126%
2/17/2025	Millennium Management LLC	878,159	$13.90M	0.0%	+53.3%	2.168%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	19,184	$0.30M	0.0%	+7.8%	0.047%
2/17/2025	Integral Health Asset Management LLC	450,000	$7.12M	0.6%	+125.0%	1.111%
2/17/2025	Janus Henderson Group PLC	14,307	$0.23M	0.0%	-84.5%	0.035%
2/17/2025	Fred Alger Management LLC	48,481	$0.77M	0.0%	-18.0%	0.120%
2/17/2025	D. E. Shaw & Co. Inc.	12,099	$0.19M	0.0%	-93.5%	0.030%
2/17/2025	Deutsche Bank AG	26,957	$0.43M	0.0%	+45.6%	0.067%
2/17/2025	DAFNA Capital Management LLC	130,316	$2.06M	0.5%	+76.7%	0.322%
2/17/2025	Braidwell LP	1,894,439	$29.99M	0.9%	+167.9%	4.676%
2/17/2025	Brevan Howard Capital Management LP	11,186	$0.18M	0.0%	+95.6%	0.028%
2/17/2025	Balyasny Asset Management L.P.	221,391	$3.51M	0.0%	-32.0%	0.547%
2/17/2025	Bank of America Corp DE	161,467	$2.56M	0.0%	-5.6%	0.399%
2/17/2025	BNP Paribas Financial Markets	46,110	$0.73M	0.0%	N/A	0.114%
2/17/2025	Algert Global LLC	12,697	$0.20M	0.0%	+26.0%	0.031%
2/17/2025	Alkeon Capital Management LLC	1,101,000	$17.43M	0.0%	-42.0%	2.718%
2/14/2025	Boxer Capital Management LLC	250,000	$3.96M	0.3%	N/A	0.617%
2/14/2025	TCG Crossover Management LLC	550,000	$8.71M	0.9%	-37.5%	1.358%
2/14/2025	Darwin Global Management Ltd.	1,687,135	$26.71M	2.5%	+10.7%	4.165%
2/14/2025	Emerald Mutual Fund Advisers Trust	155,347	$2.46M	0.2%	+37.9%	0.383%
2/14/2025	Northern Trust Corp	296,467	$4.69M	0.0%	+11.3%	0.732%
2/14/2025	The Manufacturers Life Insurance Company	40,356	$0.64M	0.0%	+140.1%	0.100%
2/14/2025	Tudor Investment Corp ET AL	15,331	$0.24M	0.0%	-22.5%	0.038%
2/14/2025	Lynx1 Capital Management LP	544,001	$8.61M	3.2%	N/A	1.343%
2/14/2025	Birchview Capital LP	15,000	$0.24M	0.2%	+114.3%	0.037%
2/14/2025	Virtus ETF Advisers LLC	3,857	$61K	0.0%	+107.5%	0.010%
2/14/2025	Nebula Research & Development LLC	71,710	$1.14M	0.1%	+433.6%	0.177%
2/14/2025	Voya Investment Management LLC	29,488	$0.47M	0.0%	-83.2%	0.073%
2/14/2025	Blue Owl Capital Holdings LP	242,633	$3.84M	0.9%	+97.9%	0.599%
2/14/2025	Price T Rowe Associates Inc. MD	909,707	$14.40M	0.0%	-39.9%	2.246%
2/14/2025	Tower Research Capital LLC TRC	22,984	$0.36M	0.0%	+1,149.8%	0.057%
2/14/2025	MetLife Investment Management LLC	18,098	$0.29M	0.0%	+6.0%	0.045%
2/14/2025	Dimensional Fund Advisors LP	155,163	$2.46M	0.0%	+1.8%	0.383%
2/14/2025	Altium Capital Management LLC	175,000	$2.77M	0.8%	+153.6%	0.432%
2/13/2025	CANADA LIFE ASSURANCE Co	7,371	$0.12M	0.0%	+207.8%	0.018%
2/13/2025	Walleye Capital LLC	197,666	$3.13M	0.0%	N/A	0.488%
2/13/2025	Barclays PLC	107,542	$1.70M	0.0%	+79.2%	0.265%
2/13/2025	F M Investments LLC	17,061	$0.27M	0.0%	N/A	0.042%
2/13/2025	ADAR1 Capital Management LLC	23,246	$0.37M	0.1%	-94.8%	0.057%
2/13/2025	Federated Hermes Inc.	124,620	$1.97M	0.0%	N/A	0.308%
2/13/2025	Russell Investments Group Ltd.	33,321	$0.53M	0.0%	-67.4%	0.082%
2/13/2025	Wells Fargo & Company MN	15,208	$0.24M	0.0%	+37.6%	0.038%
2/12/2025	Bryce Point Capital LLC	28,127	$0.45M	0.1%	N/A	0.069%
2/12/2025	Geode Capital Management LLC	765,436	$12.12M	0.0%	+5.5%	1.889%
2/12/2025	Alliancebernstein L.P.	137,424	$2.18M	0.0%	-13.1%	0.339%
2/12/2025	Clearbridge Investments LLC	190,064	$3.01M	0.0%	N/A	0.469%
2/12/2025	Norges Bank	64,900	$1.03M	0.0%	N/A	0.160%
2/12/2025	NEOS Investment Management LLC	35,663	$0.57M	0.0%	+28.4%	0.088%
2/12/2025	JPMorgan Chase & Co.	213,431	$3.38M	0.0%	+585.9%	0.527%
2/11/2025	EntryPoint Capital LLC	11,535	$0.18M	0.1%	N/A	0.028%
2/11/2025	Emerald Advisers LLC	244,633	$3.87M	0.2%	+57.3%	0.604%
2/11/2025	Vanguard Group Inc.	1,957,109	$30.98M	0.0%	+5.4%	4.831%
2/11/2025	Fox Run Management L.L.C.	22,213	$0.35M	0.1%	+261.5%	0.055%
2/11/2025	KLP Kapitalforvaltning AS	5,700	$90K	0.0%	N/A	0.014%
2/11/2025	American Century Companies Inc.	328,920	$5.21M	0.0%	+10.5%	0.812%
2/10/2025	Swiss National Bank	59,000	$0.93M	0.0%	+4.8%	0.146%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	29,146	$0.46M	0.0%	N/A	0.072%
2/7/2025	AlphaQuest LLC	3,596	$57K	0.0%	+469.0%	0.009%
2/6/2025	Charles Schwab Investment Management Inc.	279,682	$4.43M	0.0%	+7.5%	0.690%
2/4/2025	Bank of New York Mellon Corp	97,878	$1.55M	0.0%	+2.6%	0.242%
2/4/2025	Y Intercept Hong Kong Ltd	74,255	$1.18M	0.1%	+1,910.2%	0.183%
2/3/2025	Handelsbanken Fonder AB	10,800	$0.17M	0.0%	+11.3%	0.027%
1/24/2025	China Universal Asset Management Co. Ltd.	8,589	$0.14M	0.0%	+19.0%	0.021%
1/21/2025	Exchange Traded Concepts LLC	6,242	$99K	0.0%	N/A	0.015%
1/17/2025	SG Americas Securities LLC	24,493	$0.39M	0.0%	N/A	0.060%
1/14/2025	Assenagon Asset Management S.A.	64,937	$1.03M	0.0%	-71.0%	0.160%
11/27/2024	Franklin Resources Inc.	288,234	$17.44M	0.0%	-28.0%	0.712%
11/16/2024	Geode Capital Management LLC	725,621	$42.15M	0.0%	+6.8%	1.791%
11/15/2024	Barclays PLC	60,014	$3.48M	0.0%	+140.1%	0.148%
11/15/2024	Y Intercept Hong Kong Ltd	3,694	$0.22M	0.0%	-90.3%	0.009%
11/15/2024	Wellington Management Group LLP	14,949	$0.87M	0.0%	N/A	0.037%
11/15/2024	State Street Corp	1,113,590	$64.67M	0.0%	-8.8%	2.749%
11/15/2024	Readystate Asset Management LP	4,603	$0.27M	0.0%	-96.0%	0.011%
11/15/2024	Point72 DIFC Ltd	19,255	$1.12M	0.0%	+9.8%	0.048%
11/15/2024	Point72 Asset Management L.P.	947,570	$55.03M	0.1%	+155.9%	2.339%
11/15/2024	Parkman Healthcare Partners LLC	421,782	$24.49M	3.1%	+112.3%	1.041%
11/15/2024	Janus Henderson Group PLC	92,110	$5.35M	0.0%	+543.8%	0.227%
11/15/2024	HighVista Strategies LLC	52,107	$3.03M	1.0%	+32.9%	0.129%
11/15/2024	Holocene Advisors LP	843,110	$48.96M	0.2%	+22.5%	2.081%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	3,844	$0.22M	0.0%	+36.7%	0.009%
11/15/2024	Erste Asset Management GmbH	20,700	$1.17M	0.0%	N/A	0.051%
11/14/2024	PFM Health Sciences LP	101,050	$5.87M	0.3%	+203.0%	0.249%

Data available starting January 2016

See Full Table

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States. The company's lead product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, as well as in patients with myelofibrosis. It also develops KER-012, which is in Phase II clinical trial to treat pulmonary arterial hypertension and cardiovascular disorders; and KER-065 that is in Phase I clinical trial for the treatment of obesity and neuromuscular diseases. In addition, the company has collaboration and license agreement with Hansoh (Shanghai) Healthtech Co., Ltd. to develop, manufacture, and commercialize KER-050 and licensed products containing KER-050. Keros Therapeutics, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Today's Range

Now: $14.07

$13.42

$14.20

50 Day Range

MA: $11.17

$9.55

$14.07

52 Week Range

Now: $14.07

$9.12

$72.37

Volume

1,347,070 shs

Average Volume

783,889 shs

Market Capitalization

$570.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.39

Who are the company insiders with the largest holdings of Keros Therapeutics?: Keros Therapeutics' top insider shareholders include:
Adar1 Capital Management, Llc (Major Shareholder)
Carl L Gordon (Director)
Keith Regnante (CFO)
Learn More about top insider investors at Keros Therapeutics.
Who are the major institutional investors of Keros Therapeutics?: Keros Therapeutics' top institutional shareholders include:
Rhumbline Advisers — 0.11%
FNY Investment Advisers LLC — 0.01%
GAMMA Investing LLC — 0.01%
Learn More about top institutional investors of Keros Therapeutics stock.
Which major investors are buying Keros Therapeutics stock?: During the previous quarter, KROS stock was purchased by institutional investors including:
Rhumbline Advisers
FNY Investment Advisers LLC
GAMMA Investing LLC